Press releases
-
Wednesday, June 5, 2013Ferring announces second $3 million donation to the Royal Textile Academy of Bhutan
Read Press Release -
Thursday, May 2, 2013
“Ferring presents phase III data for a controlled release misoprostol vaginal delivery system for labour induction atthe First European Congress on Intrapartum Care”
Read Press Release -
Wednesday, June 5, 2013
“Ferring Pharmaceuticals begins phase III trials of elobixibat, new compound with novel mechanism of action forchronic idiopathic constipation”
Read Press Release -
Wednesday, June 5, 2013
“Ferring Pharmaceuticals begins phase III trials of elobixibat, new compound with novel mechanism of action forchronic idiopathic constipation”
Read Press Release
Helen Gallagher
Senior Director
Corporate Communications
Tel: +41 58 301 00 51
Patrick Gorman
Senior Director
Corporate Communications
Tel: +41 58 301 00 53
Corporate Communications
Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10
Email
